News

  1. Home
  2. News

PolyBio Scientists Present Long COVID Tissue Findings at USA–Saudi Biotech Alliance Summit

Medford, MA, January 31, 2026 — Amy Proal PhD, President of the PolyBio Research Foundation, alongside PolyBio-supported researchers Timothy Henrich MD...

PolyBio Research Foundation Joins HHS Lyme Disease Roundtable Meeting as New Clinical Trial Advances Treatment for Chronic Babesiosis

Washington, DC — December 15, 2025 — This week, PolyBio Research Foundation President Dr. Amy Proal attended a U.S. Department of...

PolyBio Research Foundation Organizes Banbury Meeting on Accessible Diagnostics of Pathogen Tissue Persistence

Lloyd Harbor, NY — December 7–10, 2025 — PolyBio Research Foundation convened and funded a Banbury Meeting at Cold Spring Harbor Laboratory,...

New machine learning study identifies distinct Long COVID symptom endotypes across four major cohorts

PolyBio-supported research uses questionnaire-based machine learning to successfully identify global Long COVID endotypes.A new preprint titled “Machine Learning Analysis of Post-Acute...

PolyBio adds key resources to Long COVID immunotherapy pilot trial analysis

Funds will allow gut, lymph node, and blood samples collected from trial participants to be maximally analyzed for signs of SARS-CoV-2...

New microfluidic blood test accurately identifies microclots in Long COVID children

Medford, MA [October 11, 2025] - Long COVID affects approximately one in five children following acute SARS-CoV-2 infection, often causing fatigue, brain fog, and pain that can disrupt school performance and long-term development.

New grant expands Long COVID lymph node study

PolyBio and the Wallace Research Foundation have awarded a new grant to Dr. Michela Locci at the University of Pennsylvania to investigate impaired antibody responses in Long COVID. Building on prior findings that B cells in some patients generate weaker, short-lived antibodies, the study will explore whether Epstein-Barr virus disrupts immune function using advanced single-cell and organoid approaches.

Infections can be major drivers of aging processes, new PolyBio review delineates

Medford MA, August 12, 2025 - A new scientific review written by PolyBio's core team challenges the long-held assumption that human aging unfolds in a sterile environment.

PolyBio President Amy Proal Joins Invivyd’s SPEAR Study Group to Advance Monoclonal Antibody Trials for Long COVID

Dr. Proal, along with other members of the Long COVID Research Consortium, have joined SPEAR, a leading clinical and translational research team convened by Invivyd, Inc. to accelerate Long COVID clinical trials.

PolyBio Research Appoints Sarah Kalloch as Chief Operating and Innovation Officer

Medford MA July 17, 2025 - PolyBio Research Foundation announces the appointment of Sarah Kalloch as its new Chief Operating and Innovation Officer.

PolyBio’s Dr. Amy Proal clarifies infectious drivers of aging at Boston Summit

Medford MA, June 19 – PolyBio President and Research Director Dr. Amy Proal joined the Boston Aging Code Summit this past...

PolyBio and WE&ME supported study identifies two distinct ME/CFS subtypes

Medford MA - May 16, 2025 - A PolyBio-supported study published today in the Journal of Immunology sheds new light on the myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) disease process.

Newsletter

PolyBio scientists are active at conferences and frequent guests on podcasts. Learn more about these events, get project updates, and meet the PolyBio team via our Newsletter.

Sign Up